Ambry Debuts Agilent-Made Stem Cell CGH Array
January 19, 2010
Ambry Debuts Agilent-Made Stem Cell CGH Array
Ambry said the chip offers a "higher-resolution approach" to standard karyotyping for stem cells, as well as increased coverage in known stem cell- and cancer-associated genes compared to Agilent's standard 44K CGH array.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Signature Genomics to Adopt Agilent Platform in Light of Roche's Planned Departure from Array Market
July 31, 2012 / BioArray News - With Future of Roche NimbleGen Arrays in Question, Customers Bet on New Platforms
July 17, 2012 / BioArray News - Ambry Genetics, Looking to Entice Pharma, Rolls out CHO Cell Expression Array
January 31, 2012 / BioArray News - Cell Line Genetics to Offer Ambry Genetics' StemArray to Regenerative Medicine Market
June 21, 2011 / BioArray News - Ambry Genetics Certified as Agilent Provider
September 1, 2009 / GenomeWeb Daily News